IL125522A0 - Methods of increasing sphincter competence - Google Patents

Methods of increasing sphincter competence

Info

Publication number: IL125522A0
Authority: IL; Israel
Prior art keywords: methods; sphincter competence; increasing sphincter; increasing; competence
Prior art date: 1996-01-29

Application number

IL12552297A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-29

Filing date

1997-01-27

Publication date

1999-03-12

1996-02-15 Priority claimed from GBGB9603147.1A external-priority patent/GB9603147D0/en

1997-01-27 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-03-12 Publication of IL125522A0 publication Critical patent/IL125522A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL12552297A 1996-01-29 1997-01-27 Methods of increasing sphincter competence IL125522A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1077196P	1996-01-29	1996-01-29
GBGB9603147.1A GB9603147D0 (en)	1996-02-15	1996-02-15	Methods of increasing sphincter competence
PCT/US1997/001159 WO1997026876A1 (en)	1996-01-29	1997-01-27	Methods of increasing sphincter competence

Publications (1)

Publication Number	Publication Date
IL125522A0 true IL125522A0 (en)	1999-03-12

Family

ID=26308706

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12552297A IL125522A0 (en)	1996-01-29	1997-01-27	Methods of increasing sphincter competence

Country Status (11)

Country	Link
EP (1)	EP0910378A4 (no)
JP (1)	JP2000503991A (no)
CN (1)	CN1213303A (no)
AU (1)	AU732473B2 (no)
CZ (1)	CZ235598A3 (no)
EA (1)	EA001103B1 (no)
HU (1)	HUP9903440A3 (no)
IL (1)	IL125522A0 (no)
NO (1)	NO983453L (no)
NZ (1)	NZ331085A (no)
WO (1)	WO1997026876A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1113007A1 (en)	1999-12-24	2001-07-04	Pfizer Inc.	Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
WO2002003989A2 (en) *	2000-07-06	2002-01-17	Wyeth	Use of substituted indole compounds for treating sphincter incontinence
US6376486B1 (en)	2000-07-06	2002-04-23	American Home Products Corporation	Methods of inhibiting sphincter incontinence
US6455568B2 (en)	2000-07-06	2002-09-24	Wyeth	Combination therapy for inhibiting sphincter incontinence
US20040248989A1 (en)	2003-06-05	2004-12-09	Risto Santti	Method for the treatment or prevention of lower urinary tract symptoms
US7825107B2 (en)	2006-05-22	2010-11-02	Hormos Medical Ltd.	Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5391557A (en) *	1993-10-15	1995-02-21	Eli Lilly And Company	Methods for the treatment of peri-menopausal syndrome
US5492927A (en) *	1993-12-21	1996-02-20	Eli Lilly And Company	Non-peptide tachykinin receptor antagonists to treat allergy
US6562862B1 (en) *	1994-10-20	2003-05-13	Eli Lilly And Company	Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
AU3899595A (en) *	1994-12-02	1996-06-19	Mostyn Farmer	Golf stance training aid
US5789442A (en) *	1996-01-18	1998-08-04	Schering Aktiengesellschaft	Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

1997
- 1997-01-27 EA EA199800676A patent/EA001103B1/ru not_active IP Right Cessation
- 1997-01-27 CZ CZ982355A patent/CZ235598A3/cs unknown
- 1997-01-27 AU AU18386/97A patent/AU732473B2/en not_active Ceased
- 1997-01-27 EP EP97903959A patent/EP0910378A4/en not_active Withdrawn
- 1997-01-27 CN CN97191918A patent/CN1213303A/zh active Pending
- 1997-01-27 NZ NZ331085A patent/NZ331085A/en unknown
- 1997-01-27 HU HU9903440A patent/HUP9903440A3/hu unknown
- 1997-01-27 IL IL12552297A patent/IL125522A0/xx unknown
- 1997-01-27 WO PCT/US1997/001159 patent/WO1997026876A1/en not_active Application Discontinuation
- 1997-01-27 JP JP9527033A patent/JP2000503991A/ja active Pending
1998
- 1998-07-27 NO NO983453A patent/NO983453L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1997026876A1 (en)	1997-07-31
HUP9903440A3 (en)	2000-07-28
AU1838697A (en)	1997-08-20
EA199800676A1 (ru)	1999-02-25
HUP9903440A2 (hu)	2000-06-28
JP2000503991A (ja)	2000-04-04
EP0910378A1 (en)	1999-04-28
NZ331085A (en)	2000-06-23
NO983453L (no)	1998-09-11
NO983453D0 (no)	1998-07-27
CN1213303A (zh)	1999-04-07
EA001103B1 (ru)	2000-10-30
AU732473B2 (en)	2001-04-26
CZ235598A3 (cs)	1999-03-17
EP0910378A4 (en)	1999-06-23

Publication	Publication Date	Title
PL330990A1 (en)	1999-06-21	Improved method of halogenating isomo-olefinic copolymers
PL331771A1 (en)	1999-08-02	Method of improving seeds
PL333364A1 (en)	1999-12-06	Novel compounds and method of using them
IL125829A0 (en)	1999-04-11	Method of sharing cryptokey
EP0914115A4 (en)	2002-07-31	NEUROPROTECTION METHODS
PL318452A1 (en)	1997-08-18	Method of obtaining peroxyperfluoropolyoxyalkylenes
EP1017459A4 (en)	2000-07-12	GAME OF CHANCE
PL330400A1 (en)	1999-05-10	Method of obtaining azacyclohexapeptides
HU9702480D0 (en)	1998-03-02	New polymorphe modification of doxazosin-mesylate
IL125522A0 (en)	1999-03-12	Methods of increasing sphincter competence
GB9602704D0 (en)	1996-04-10	Structure of perculator
CY2590B2 (en)	2009-11-04	Preparation of 1-butyl-4-piperidinylmethylamine
PL332077A1 (en)	1999-08-30	Method of obtaining omepraole
HU9702479D0 (en)	1998-03-02	New polymorphe modification of doxazosin-mesylate
PL313419A1 (en)	1997-09-29	Method of obtaining beta-naphtole
PL333977A1 (en)	2000-01-31	Method of obtaining benzisothiazolyn-3-ones
PL321479A1 (en)	1998-02-16	Method of polymerising isocyanatges
PL328082A1 (en)	1999-01-04	Method of improving sphincter competence
GB9603147D0 (en)	1996-04-17	Methods of increasing sphincter competence
GB9616563D0 (en)	1996-09-25	Compounds and methods
GB2317119B (en)	2000-10-25	Educational system of shapes
PL332075A1 (en)	1999-08-30	Method of obtaining nizathidine
PL317788A1 (en)	1998-07-06	Method of obtaining 3-isocyanate-propylsilane
EP0934345A4 (en)	1999-12-22	CONNECTIONS AND PROCEDURE
PL313849A1 (en)	1997-10-27	Beta-aminoesters of o-hydrobenzylamides